Literature DB >> 34307805

RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice.

Shrikant Pawar1, Aina Bellver-Sanchis2, Christian Griñán-Ferré2.   

Abstract

Growing evidence demonstrates the epigenetic modulation as a key event in Alzheimer's disease (AD) pathology. Furthermore, recent data suggests that the epigenetic regulation by the methyltransferase G9a is a crucial mechanism involved in learning and memory formation. Taking this into account, we hereby provide genomics data from pharmacological intervention with UNC0642, a potent and selective G9a/GLP in SAMP8 mice, a model of Alzheimer's disease (AD). We have generated novel RNA-seq and miRNA-seq data for three groups, healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5 mg/Kg). Thus, the new data can be used to find miRNA regulation, and the mRNA's modified in AD under G9a/GLP inhibition.
© 2021 Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Epigenetics; G9a/GLP; RNA seq; SAMP8; SAMR1; UNC0642

Year:  2021        PMID: 34307805      PMCID: PMC8257974          DOI: 10.1016/j.dib.2021.107114

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table

Value of the Data

This data can be used to find miRNA regulation, and the mRNA's modified in Alzheimer's disease under G9a/GLP inhibition. Many researcher groups focusing on how epigenetic modifications contribute to specific aspects of Alzheimer's disease can be benefited with this data. Presented genomics data from pharmacological intervention with UNC0642, a potent and selective G9a/GLP in SAMP8 mice, a model of Alzheimer's disease can provide insights into promising pharmacological targets.

Data Description

We have presented novel RNA-seq and miRNA-seq data generated for three groups, healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5 mg/Kg) during 4 weeks in drinking water administration. Senescence-accelerated mouse prone 8 (SAMP8) is a naturally occurring mouse line that displays a phenotype of accelerated aging, while SAMR1 mice represent a normal aging control [2], [3], [4]. This new data can be used to find miRNA regulation, and the mRNA's modified in AD under G9a/GLP inhibition. We have provided the overall distribution of significant genes in comparison SAMR1 Ct vs SAMP8 Ct, and comparison SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg)), with significant miRNA's (fold change) in a heatmap. The isolation of volume and concentrations for RNA-seq and miRNA-seq experiments is provided in Table 1 and miRNA-seq comparisons are provided in Supplementary files 1, 2, 3 and 4.
Table 1

RNA isolation volume and concentrations for RNA-seq and miRNA-seq experiments.

Sample NameVolume(ul)SampleTypeNanodrop(ng/ul)A260A280260/280RIN
SAMR1 Ct15RNA433.710.845.2862.055.6
SAMP8 Ct15RNA1233.0761.5132.034.6
SAMP8 UNC0642 (5 mg/Kg)15RNA146.93.6731.7952.058.1
RNA isolation volume and concentrations for RNA-seq and miRNA-seq experiments.

RNA-seq data

With comparison, SAMR1 Ct vs SAMP8 Ct, 3600 unique ensemble ids were generated from DESeq2 package (Supplementary file 1). With a fold change of ≧ 0.5, 78 genes were found to be significantly upregulated while 62 genes were found to be downregulated in SAMP8 Ct with a fold change of ≦ −0.5. Fig. 1 (Left) provides overall distribution of these significant genes. With comparison, SAMP8 Ct vs SAMP8 UNC0642, 3126 unique ensemble ids were generated from DESeq2 package (Supplementary file 2). With a fold change of ≧ 0.5, 140 genes were found to be significantly upregulated while 159 genes were found to be downregulated in SAMP8 UNC0642 with a fold change of ≦ −0.5. Fig. 1 (Right) provides overall distribution of these significant genes.
Fig. 1

Overall distribution of significant genes (Left: Comparison SAMR1 Ct vs SAMP8 Ct, Right: Comparison SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg)).

Overall distribution of significant genes (Left: Comparison SAMR1 Ct vs SAMP8 Ct, Right: Comparison SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg)). POU class 3 homeobox 2 (POU3F2), SATB homeobox 2 (SATB2), T-box, brain 1 (TBR1), ankyrin repeat domain 52 (ANKRD52), calcium/calmodulin dependent protein kinase II inhibitor 1 (CAMK2N1) where some of the top up regulated genes in SAMP8 treated with UNC0642 (5 mg/Kg), while T-cell lymphoma invasion and metastasis 1 (TIAM1), cell adhesion molecule 1 (CADM1), clathrin light chain A (CLTA), importin 7 (IPO7) where some of the top down regulated genes in SAMP8 UNC0642 condition.

miRNA-seq data

Comparison SAMR1 Ct vs SAMP8 Ct had 147 miRNA's, while comparison SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg)with 25 miRNA's were found to have a significant P value (<0.05) and fold change (>2). The list of these miRNA's is provided in files Supplementary file 3 and Supplementary file 4. Fig. 2 depicts the heatmap of significant miRNA's observed in compared conditions.
Fig. 2

Heatmap (fold change) of significant miRNA's observed in comparisons SAMR1 Ct vs SAMP8 Ct and SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg).

Heatmap (fold change) of significant miRNA's observed in comparisons SAMR1 Ct vs SAMP8 Ct and SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg).

Data

The early cognitive impairment in Alzheimer's Disease (AD) can be mistaken for premature aging correlating with epigenetic changes occurring at a younger age. Exactly how epigenetic modifications contribute to specific aspects of AD is the focus of many researcher groups. The G9a/GLP complex plays a role in learning and memory since its inhibition participates in the maintenance of long-term potentiation (LTP) and Long-Term Depression (LTD). The inhibition of this complex increases the expression of memory permissive genes such as Bdnf, previously repressed, confirming the transcriptional modifications modulated by G9a/GLP complex. Due to the transcription repression produced by G9a/GLP through its repressive mark H3K9me2 and given the evidence demonstrating the implication of the G9a/GLP complex in different human diseases, it has emerged as a promising pharmacological target [1]. Therefore, chromatin modifications induced by drugs could offer an opportunity for novel therapeutic strategies in AD.

Experimental Design, Materials and Methods

Design

Total RNA from cells was isolated with Quick Biology's miRNA-seq [5]. One of the biggest limitations to the small RNA library protocol are the insert-less 5′adapter and 3′adapter ligations that form what are called adapter dimers. These dimers compete for resources during RT-PCR. When over-amplified, these ~120 bp products can contaminate true 150 bp microRNA library bands. Quick Biology's optimized protocol utilizing modified oligonucleotides is used to eliminate the reverse-transcription of adapter dimers. We used multiplex miRNA libraries in one run of Illumina sequencing, to determine the level of multiplexing or number of libraries to pool together, yielding reads between 5 and 10 million reads per library. Sequence small RNA libraries using a 1 × 50 or 1 × 75 bp sequencing run were utilized, and for miRNA expression profiling, 100K–5 M mapped reads per sample was considered. We have separated control and treatment groups into 3 categories, SAMR1 Ct are a healthy mice control group, SAMP8 Ct are control mice group, and SAMP8 UNC0642 (5 mg/Kg) are treated mice group. RNA isolation volume and concentrations are provided in Table 1. Two replicates for samples SAMR1 Ct, SAMP8 Ct and SAMP8 UNC0642 (5 mg/Kg) were aligned with reference genome using HISAT aligner. It is a fast and sensitive spliced alignment program based on the Burrows-Wheeler transform and hierarchical indexing employing one global FM index representing the whole genome, and many separate local FM indexes for small regions collectively covering the genome. All the aligned bam files were separately processed through FeatureCounts for calculating counts for each identifier. FeatureCounts is a lightweight read counting program that can be used to count both gDNA-seq and RNA-seq reads for genomic features in SAM/BAM files. Finally, DESeq2 package was implemented to test for differential expression between conditions, SAMR1 Ct vs SAMP8 Ct and SAMP8 Ct vs SAMP8 UNC0642 (5 mg/Kg). DESeq2 estimates variance-mean dependence in count data from high-throughput sequencing assays and test for differential expression based on a model using the negative binomial distribution. miRNA was analyzed using sRNA Detection module of Oasis [6]. It examines sample qualities, as well as quantifies known and novel sRNAs for each submitted sample. A principal component analysis (PCA) plot was generated to understand sample similarities based on sRNA expression, followed by trimming reads filtered for being too short or too long. sRNAs in Oasis are grouped into various species, including micro RNA (miRNA), piwi RNA (piRNA), small nucleolar RNA (snoRNA), small nuclear RNA (snRNA) and ribosomal RNA (rRNA). Trimming is followed by length filtering and mapping reads to the reference genome. Finally count files for all known sRNA species, as well as novel, predicted miRNAs, are generated for each sample. Differential miRNA analysis was performed using package DESeq(dds), followed by sizeFactors(dds) and dispersions(dds) [7], [8].

Transparency Document

Supplementary file 1, 2, 3, 4.

Ethics Statement

All experiments comply with the ARRIVE guidelines and carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978). Female mice were utilized for this study for all the three groups, control healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships which have or could be perceived to have influenced the work reported in this article.
SubjectBioinformatics
Specific subject areaComparative genomics
Type of dataRNA-seq and miRNA-seq Table and Figures
How data were acquiredRNA-seq and miRNA-seq was generated for three groups, healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5 mg/Kg)
Data formatRaw & analyzed
Parameters for data collectionTreatment with UNC0642 (5 mg/Kg)
Description of data collectionThe experimental features are compared between treatments healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5 mg/Kg)
Data source locationDepartment of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Avda. Joan XXIII, 27. 08,028 Barcelona, Spain.
Data accessibilityhttps://data.mendeley.com/datasets/f47bm47bcw/3Pawar, Shrikant (2020), “RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642”, Mendeley Data, v3, http://dx.doi.org/10.17632/f47bm47bcw.3
  7 in total

Review 1.  G9a, a multipotent regulator of gene expression.

Authors:  Shilpa Rani Shankar; Avinash G Bahirvani; Vinay Kumar Rao; Narendra Bharathy; Jin Rong Ow; Reshma Taneja
Journal:  Epigenetics       Date:  2012-12-20       Impact factor: 4.528

2.  Senescence-accelerated Mice (SAMs) as a Model for Brain Aging and Immunosenescence.

Authors:  Atsuyoshi Shimada; Sanae Hasegawa-Ishii
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 3.  The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon
Journal:  Exp Gerontol       Date:  2005-07-18       Impact factor: 4.032

4.  Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.

Authors:  Feng Liu; Dalia Barsyte-Lovejoy; Fengling Li; Yan Xiong; Victoria Korboukh; Xi-Ping Huang; Abdellah Allali-Hassani; William P Janzen; Bryan L Roth; Stephen V Frye; Cheryl H Arrowsmith; Peter J Brown; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2013-10-31       Impact factor: 7.446

5.  Differential expression analysis for sequence count data.

Authors:  Simon Anders; Wolfgang Huber
Journal:  Genome Biol       Date:  2010-10-27       Impact factor: 13.583

6.  Oasis: online analysis of small RNA deep sequencing data.

Authors:  Vincenzo Capece; Julio C Garcia Vizcaino; Ramon Vidal; Raza-Ur Rahman; Tonatiuh Pena Centeno; Orr Shomroni; Irantzu Suberviola; Andre Fischer; Stefan Bonn
Journal:  Bioinformatics       Date:  2015-02-19       Impact factor: 6.937

7.  Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer's disease mouse model.

Authors:  Christian Griñán-Ferré; Laura Marsal-García; Aina Bellver-Sanchis; Shukkoor Muhammed Kondengaden; Ravi Chakra Turga; Santiago Vázquez; Mercè Pallàs
Journal:  Aging (Albany NY)       Date:  2019-12-04       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.